piracetam has been researched along with fluorexon in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bensliman, M; Brasseur, R; Lins, L; Mingeot-Leclercq, MP; Peuvot, J; Schanck, A; Thomas, A; Van Bambeke, F | 1 |
1 other study(ies) available for piracetam and fluorexon
| Article | Year |
|---|---|
Piracetam inhibits the lipid-destabilising effect of the amyloid peptide Abeta C-terminal fragment.
Topics: Amyloid beta-Peptides; Fluoresceins; Fluorescence; Light; Lipid Metabolism; Liposomes; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Peptide Fragments; Piracetam; Scattering, Radiation | 2003 |